Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease | Alzheimer's Research & Therapy | Full Text

Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease | Alzheimer's Research & Therapy | Full Text

Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease

Lysophosphatidic acids (LPAs) are bioactive signaling phospholipids that have been implicated in Alzheimer’s disease (AD). It is largely unknown whether LPAs are associated with AD pathology and progression fr...

Authors:Shahzad Ahmad, Adelina Orellana, Isabelle Kohler, Lutz Frölich, Itziar de Rojas, Silvia Gil, Mercè Boada, Isabel Hernández, Lucrezia Hausner, Margot H. M. Bakker, Alfredo Cabrera-Socorro, Najaf Amin, Alfredo Ramírez, Agustín Ruiz, Thomas Hankemeier and Cornelia M. Van Duijn

Citation:Alzheimer's Research & Therapy 2020 12:124

Content type:Research

 

Published on: 2 October 2020

• ViewFull Text
 
• ViewPDF